Cargando…

Type I hypersensitivity reaction as a complication of lepa

Adverse drug reaction is defined as response to a drug which is noxious and unintended, and which occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological functions. Type I hypersensitivity reaction is known as anaphylactic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Janthli, Deepa Manjunath, Chaturvedi, Ashutosh, Somashekar, Shruthi, Lohith, B. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702277/
https://www.ncbi.nlm.nih.gov/pubmed/26792959
http://dx.doi.org/10.4103/0976-0105.170583
_version_ 1782408609433387008
author Janthli, Deepa Manjunath
Chaturvedi, Ashutosh
Somashekar, Shruthi
Lohith, B. A.
author_facet Janthli, Deepa Manjunath
Chaturvedi, Ashutosh
Somashekar, Shruthi
Lohith, B. A.
author_sort Janthli, Deepa Manjunath
collection PubMed
description Adverse drug reaction is defined as response to a drug which is noxious and unintended, and which occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological functions. Type I hypersensitivity reaction is known as anaphylactic reaction which is due to immediate immunoglobulin E-mediated reaction. It is characterized by symptoms such as fever nausea, back pain, angiodema, rash, flushing, etc. Lepa generally refers to the application of pastes formed by mixing powder of herbs with water, milk, etc., and liquids. Complementary and alternative medicines are frequently used by the general population. Many people consider them to be without side effects. Ayurvedic treatment involves Shodhana (biopurification), Shaman (pacification), Bahya (external therapy), and Abhyantara karma's (internal therapy) for treating different diseases. One such bahya karma or external therapy is lepa. Even though lepa is said as “Aadhya Upakrama,” undue hypersensitivity is observed in many patients. A 60-year-old woman had an adverse reaction to lepa after being administered as an external medication. The observations were erythema, eruptions, and itching. Such case of hypersensitivity is discussed in the present study.
format Online
Article
Text
id pubmed-4702277
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-47022772016-01-20 Type I hypersensitivity reaction as a complication of lepa Janthli, Deepa Manjunath Chaturvedi, Ashutosh Somashekar, Shruthi Lohith, B. A. J Basic Clin Pharm Case Report Adverse drug reaction is defined as response to a drug which is noxious and unintended, and which occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological functions. Type I hypersensitivity reaction is known as anaphylactic reaction which is due to immediate immunoglobulin E-mediated reaction. It is characterized by symptoms such as fever nausea, back pain, angiodema, rash, flushing, etc. Lepa generally refers to the application of pastes formed by mixing powder of herbs with water, milk, etc., and liquids. Complementary and alternative medicines are frequently used by the general population. Many people consider them to be without side effects. Ayurvedic treatment involves Shodhana (biopurification), Shaman (pacification), Bahya (external therapy), and Abhyantara karma's (internal therapy) for treating different diseases. One such bahya karma or external therapy is lepa. Even though lepa is said as “Aadhya Upakrama,” undue hypersensitivity is observed in many patients. A 60-year-old woman had an adverse reaction to lepa after being administered as an external medication. The observations were erythema, eruptions, and itching. Such case of hypersensitivity is discussed in the present study. Medknow Publications & Media Pvt Ltd 2015-12 /pmc/articles/PMC4702277/ /pubmed/26792959 http://dx.doi.org/10.4103/0976-0105.170583 Text en Copyright: © Journal of Basic and Clinical Pharmacy http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Janthli, Deepa Manjunath
Chaturvedi, Ashutosh
Somashekar, Shruthi
Lohith, B. A.
Type I hypersensitivity reaction as a complication of lepa
title Type I hypersensitivity reaction as a complication of lepa
title_full Type I hypersensitivity reaction as a complication of lepa
title_fullStr Type I hypersensitivity reaction as a complication of lepa
title_full_unstemmed Type I hypersensitivity reaction as a complication of lepa
title_short Type I hypersensitivity reaction as a complication of lepa
title_sort type i hypersensitivity reaction as a complication of lepa
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702277/
https://www.ncbi.nlm.nih.gov/pubmed/26792959
http://dx.doi.org/10.4103/0976-0105.170583
work_keys_str_mv AT janthlideepamanjunath typeihypersensitivityreactionasacomplicationoflepa
AT chaturvediashutosh typeihypersensitivityreactionasacomplicationoflepa
AT somashekarshruthi typeihypersensitivityreactionasacomplicationoflepa
AT lohithba typeihypersensitivityreactionasacomplicationoflepa